^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Oral Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    PRINCIPLES OF SYSTEMIC THERAPY FOR NON-NASOPHARYNGEAL CANCERS...(Lip, Oral Cavity, Oropharynx...)...Preferred Regimens...High-dose cisplatin
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    ASCO.org
    Excerpt:
    Adjuvant chemoradiotherapy using intravenous bolus cisplatin 100 mg/m2 every 3 weeks should be offered to patients with oral cavity cancer…